Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| United Therapeutics Corporation(UTHR) | 179,499 | 167,499 | -12,000 | $41.23M | $53.36M | 9.54% | +$12.12M |
| Natera, Inc.(NTRA) | 632,714 | 474,114 | -158,600 | $57.87M | $51.34M | 9.18% | -$6.53M |
| ICON Public Limited CompanySHS(ICLR) | 149,590 | 149,590 | 0 | $50.25M | $46.89M | 8.38% | -$3.36M |
| UnitedHealth Group Incorporated(UNH) | 0 | 86,900 | +86,900 | $0 | $44.25M | 7.91% | +$44.25M |
| argenx SEADR(ARGX) | 84,590 | 88,890 | +4,300 | $33.30M | $38.23M | 6.83% | +$4.92M |
| Insmed Incorporated(INSM) | 0 | 513,700 | +513,700 | $0 | $34.42M | 6.15% | +$34.42M |
| Illumina, Inc.(ILMN) | 318,754 | 318,754 | 0 | $43.77M | $33.27M | 5.95% | -$10.50M |
| DexCom, Inc.(DXCM) | 284,918 | 275,718 | -9,200 | $39.52M | $31.26M | 5.59% | -$8.26M |
| IQVIA Holdings Inc.(IQV) | 121,895 | 121,895 | 0 | $30.83M | $25.77M | 4.61% | -$5.05M |
| Endeavour Silver Corp.(EXK) | 121,000 | 544,200 | +423,200 | $8.36M | $22.99M | 4.11% | +$14.64M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 299,700 | 524,500 | +224,800 | $13.99M | $21.56M | 3.85% | +$7.56M |
| TransMedics Group, Inc.(TMDX) | 278,655 | 132,861 | -145,794 | $20.60M | $20.01M | 3.58% | -$592.2K |
| BioMarin Pharmaceutical Inc.(BMRN) | 0 | 231,800 | +231,800 | $0 | $19.08M | 3.41% | +$19.08M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 48,356 | 76,256 | +27,900 | $7.23M | $18.53M | 3.31% | +$11.30M |
| Inspire Medical Systems, Inc.(INSP) | 122,203 | 136,603 | +14,400 | $26.25M | $18.28M | 3.27% | -$7.97M |
| Guardant Health, Inc.(GH) | 730,209 | 626,909 | -103,300 | $15.06M | $18.11M | 3.24% | +$3.04M |
| PROCEPT BioRobotics Corporation(PRCT) | 337,218 | 257,089 | -80,129 | $16.67M | $15.71M | 2.81% | -$959.7K |
| Agios Pharmaceuticals, Inc.(AGIO) | 330,830 | 330,830 | 0 | $9.67M | $14.27M | 2.55% | +$4.59M |
| Intuitive Surgical, Inc.(ISRG) | 35,590 | 28,290 | -7,300 | $14.20M | $12.58M | 2.25% | -$1.62M |
| 4d Molecular Therapeutics In | 462,911 | 462,911 | 0 | $14.75M | $9.72M | 1.74% | -$5.03M |
| Lantheus Holdings, Inc.(LNTH) | 43,200 | 43,200 | 0 | $2.69M | $3.47M | 0.62% | +$779.8K |
| Viking Therapeutics, Inc.(VKTX) | 45,000 | 45,000 | 0 | $3.69M | $2.39M | 0.43% | -$1.30M |
| Werewolf Therapeutics, Inc.(HOWL) | 700,000 | 700,000 | 0 | $4.54M | $1.71M | 0.31% | -$2.83M |
| Immunocore Holdings plcADS(IMCR) | 46,300 | 46,300 | 0 | $3.01M | $1.57M | 0.28% | -$1.44M |
| GRAIL, Inc.(GRAL) | 0 | 53,124 | +53,124 | $0 | $816.5K | 0.15% | +$816.5K |
| 10x Genomics, Inc.CL A(TXG) | 135,059 | 0 | -135,059 | $5.07M | $0 | — | -$5.07M |
| Danaher Corporation(DHR) | 113,685 | 0 | -113,685 | $28.39M | $0 | — | -$28.39M |
| Fusion Pharmaceuticals Inc | 579,769 | 0 | -579,769 | $12.36M | $0 | — | -$12.36M |
| Pacific Biosciences of California, Inc.(PACB) | 2,167,021 | 0 | -2,167,021 | $8.13M | $0 | — | -$8.13M |
| Sarepta Therapeutics, Inc.(SRPT) | 103,256 | 0 | -103,256 | $13.37M | $0 | — | -$13.37M |